Mental Health

Menopause and Mental Health

Creator: Dr Nadira Awal
Published: 2026-01-15

Anxiety, low mood, menopausal rage — and what actually helps.

By Dr Nadira AwalBMS Specialist4 min readMedically reviewed 9 July 2026

Open leather journal with fountain pen and a sprig of eucalyptus on cream linen

Menopause is a high-risk window for new or recurrent depression. Recognising this — and not defaulting straight to antidepressants — matters.

Perimenopause is a recognised high-risk window for new or recurrent depression, anxiety and even, in a small but significant minority, suicidal ideation. The Massachusetts Women’s Health Study, the SWAN cohort and multiple UK datasets all show that women’s risk of a first episode of depression is 2–4 times higher in the perimenopausal transition than at any other point in adult life — including the postnatal period. Naming this — and not defaulting straight to antidepressants — matters. NICE NG23 is clear that HRT should be considered first for low mood arising in perimenopause. Getting the sequence right can change the course of a decade.

Why hormones matter for mood

Oestrogen modulates serotonin, dopamine and noradrenaline synthesis and receptor sensitivity — the same pathways antidepressants target.
Oestrogen supports BDNF (brain-derived neurotrophic factor) and hippocampal neuroplasticity — critical for mood regulation.
Progesterone metabolites (allopregnanolone) act on GABA-A receptors — the same site as benzodiazepines and alcohol; erratic swings drive anxiety and irritability.
Fluctuating oestrogen — not just low oestrogen — is the biggest mood destabiliser. That’s why perimenopause (the most volatile hormonal phase) is riskier than postmenopause.
Sleep loss compounds every mood symptom; addressing sleep is treatment, not add-on advice.

The typical clinical picture

Low mood, anhedonia, tearfulness — often described as ‘not myself’ rather than classical depression.
New or worsening anxiety, waking at 3–4 am with racing thoughts.
Irritability and ‘menopause rage’ — disproportionate reactions to small triggers.
Loss of confidence at work, avoidance of social situations, dread of previously easy activities.
Intrusive thoughts, health anxiety, catastrophising.
A subset of women describe suicidal ideation — always take this seriously and seek urgent support.

Woman sitting quietly by a window looking thoughtful — Perimenopause is the highest-risk window in adult life for a first episode of depression — naming it correctly is the first step to treating it correctly.

What NICE and BMS say

NICE NG23: consider HRT for low mood arising in the context of menopause, before or alongside antidepressants.
CBT is recommended for menopausal anxiety, low mood and sleep disturbance.
Antidepressants remain appropriate where clinical depression is diagnosed, but should not be the automatic first step for perimenopausal mood symptoms.
There is no evidence that SSRIs prevent hot flushes better than HRT in women who can take HRT.

A layered approach that actually works

HRT — usually transdermal oestrogen with micronised progesterone — to stabilise the hormonal ground. Expect early sleep benefits within 2 weeks, mood benefits over 4–8 weeks.
CBT or menopause-specific talking therapy for entrenched patterns and coping strategies.
SSRIs (sertraline, escitalopram) or SNRIs (venlafaxine, duloxetine) where clinical depression is present or HRT is contraindicated.
Exercise: 150 minutes of moderate cardio + 2 strength sessions a week — antidepressant-strength effect in mild-to-moderate depression.
Light exposure: 15 minutes of morning daylight, ideally within an hour of waking.
Sleep as intervention: address insomnia and night sweats directly.
Social connection: isolation is a major amplifier of perimenopausal mood symptoms.
Alcohol reduction: even 1–2 units nightly worsens mood, sleep and anxiety in this window.

Woman in a CBT session with a therapist taking notes — NICE recommends CBT alongside HRT for menopausal low mood and anxiety — not as a replacement for hormone therapy.

Combining HRT and antidepressants safely

Many women benefit from both — this is not either/or.
If already on an antidepressant that is helping, do not stop it when starting HRT; review at 3–6 months.
If HRT alone controls symptoms, a slow, guided antidepressant taper can be discussed with the prescriber.
Avoid abrupt SSRI/SNRI stops — always taper.

Testosterone and mood

Testosterone is not a licensed treatment for depression but can help energy, motivation and cognitive engagement in women who remain flat despite optimised oestrogen.
It is added after 3–6 months of stable oestrogen, not as a first-line mood treatment.

Red flags — seek urgent help today

Thoughts of self-harm or suicide: contact your GP the same day, call NHS 111 (option 2 for mental health), or Samaritans on 116 123 (24/7, free).
Feeling unable to keep yourself safe: A&E is appropriate.
Rapid decline in function, weight loss, inability to eat or sleep at all — urgent GP or crisis team review.
New psychotic symptoms — urgent psychiatric assessment.

What to bring to your appointment

A note of your symptoms and their timing across the menstrual cycle (if still cycling).
PHQ-9 and GAD-7 scores if you can — free, 2 minutes each, online.
Past history of depression, postnatal depression, PMDD, or antidepressant use.
Any current medications and family mental-health history.

Key takeaway

Perimenopausal mood symptoms are a hormonal event as much as a psychological one. HRT first, CBT and lifestyle in parallel, antidepressants where clinically needed — and urgent help for suicidal thoughts. Naming it correctly is the first step to treating it correctly.

How Dr Awal approaches this in clinic

Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.

A detailed 60 minute first appointment — no rushed 10-minute slots.
Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
Body-identical HRT considered first-line where appropriate.
Shared-care letters sent to your NHS GP so treatment can continue affordably.
Follow-up at 3 months to fine-tune your regimen and address side effects.
Ongoing annual reviews so your plan evolves with you.

Common questions we hear about this

Do I need to be at a certain age to be seen?

No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.

Will my GP continue the prescription?

In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.

What if I've tried HRT before and it didn't suit me?

Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.

How long will I need to stay on treatment?

There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.

Where do you see patients?

All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.

About the author

Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.

Sources & further reading

General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.

Talk it through